🔗 Share this article

Texas Attorney General Paxton is taking legal action against the manufacturers of Tylenol, alleging the corporations withheld alleged dangers that the drug posed to pediatric neurological development.

The court filing comes four weeks after Former President Trump advocated an unverified association between using Tylenol - also known as paracetamol - during pregnancy and autism in children.

The attorney general is taking legal action against J&J, which once produced the drug, the only pain reliever recommended for pregnant women, and Kenvue, which currently produces it.

In a declaration, he claimed they "misled consumers by gaining financially from discomfort and marketing drugs regardless of the potential hazards."

Kenvue asserts there is no credible evidence linking Tylenol to autism spectrum disorder.

"These companies deceived for years, deliberately risking millions to increase profits," Paxton, from the Republican party, stated.

The company said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the potential impact that could have on the well-being of American women and children."

On its website, Kenvue also mentioned it had "continuously evaluated the relevant science and there is insufficient valid information that indicates a established connection between consuming paracetamol and autism."

Organizations representing doctors and health professionals concur.

ACOG has declared paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to manage pain and elevated temperature, which can create serious health risks if not addressed.

"In multiple decades of research on the use of paracetamol in gestation, zero credible investigations has definitively established that the consumption of acetaminophen in any period of pregnancy results in neurological conditions in children," the association stated.

The court filing references recent announcements from the Trump administration in arguing the medication is reportedly hazardous.

In recent weeks, the former president generated worry from health experts when he advised pregnant women to "struggle intensely" not to take Tylenol when ill.

The FDA then released a statement that medical professionals should think about restricting the usage of acetaminophen, while also mentioning that "a direct connection" between the drug and autism spectrum disorder in young ones has not been proven.

Health Secretary Kennedy, who manages the FDA, had vowed in spring to initiate "a massive testing and research effort" that would establish the origin of autism in a matter of months.

But authorities warned that identifying a unique factor of autism spectrum disorder - thought by researchers to be the outcome of a intricate combination of genetic and external influences - would prove challenging.

Autism is a type of permanent neurological difference and disability that affects how individuals perceive and engage with the surroundings, and is recognized using doctors' observations.

In his legal document, the attorney general - a Trump ally who is campaigning for the Senate - asserts Kenvue and J&J "deliberately disregarded and tried to quiet the evidence" around paracetamol and autism.

The lawsuit aims to force the firms "destroy any promotional materials" that states Tylenol is reliable for expectant mothers.

The Texas lawsuit mirrors the grievances of a group of guardians of children with autism and attention deficit hyperactivity disorder who sued the makers of acetaminophen in recently.

Judicial authorities rejected the legal action, stating studies from the parents' expert witnesses was not conclusive.